ATTACHMENT I Wyeth-Ayerst Comments to 2000 Draft L,abe&ng Guidance for Combined Oral Contraceptives Wyeth-Ayerst Comments to June 2000 Draft Guidance Entitled “Combined Oral Contraceptives - Labeling for Health Care Providers and Patients”

248-255 Trussel

Family Planning Perspectives year, while induced and spontaneous abortions among teenagers cost more than $180 million.* Additional resources are required to treat sexually transmitted diseases (STDs), acquired by about three million teenagers annually,5 and for programs such as the Special Supplemental Program for Women, Infants and Children. Most sexually active female adolescents are trying ...

Newer progestogens.

OBJECTIVE To review the literature on the most recent progestogens to be developed, to provide clinical comparisons with older progestogens and to look at the potential of products not yet marketed. DATA SOURCES Searches of Medline and Popline together with requests for bibliographies from the Population Council, Wyeth-Ayerst Research and Schering Health Care. STUDY SELECTION Information fr...

Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development.

We assessed the influence of hormonal (oral, injectable, or levonorgestrel [Norplant, Wyeth-Ayerst, Philadelphia, PA]) and barrier methods of contraception on the risk of cervical squamous intraepithelial lesions (SIL), while adjusting for high-risk (HR) HPV infection. Subjects were women receiving family planning services through the state health department clinics from 1995 to 1998. We select...

Negro-Vilar to Join Wyeth-Ayerst

Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.

I would like to thank Drs Terplan and Zuckerman for their comments on the recently published position statement, which myself and the other cosignatory authors take very seriously. If I may summarise Drs Terplan and Zuckerman‘s argument. It starts with the assumption that there is now clear evidence proving that levonorgestel (LNG)and norethisterone acetate (NETA)-containing combined oral contr...